Since HOMA-IR is commonly affected by exogenous insulin injection in diabetes patients (54), we believed that TyG-BMI could replace other IR indexes in clinical settings as an effective one to evaluate the testosterone decrease or deficiency. The gene discussed is INS; the disease is diabetes mellitus.